Hengrui Pharma News and Activities

Hengrui Pharma is one of the...

• CSI 300;
• Forbes Global 2000 (#1201);
• TOB Iconic 10,000.

Hengrui Pharma is a company listed under the stock ticker 600276 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Hengrui Pharma

• Jo Feng, President
• Congzhao Guo, Director
• Hongbin Dai, Vice Chairman of the Board

Create your alert
to follow the executive moves at Hengrui Pharma.

Hengrui Pharma has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).
• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Hengrui Pharma

• 恒瑞医药
• 恒瑞医药

Social media about Hengrui Pharma

• Hengrui Pharma on Wikipedia, Google News & Yahoo Finance
• Hengrui Pharma on LinkedIn, X (Twitter) & YouTube